Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Advances in Radiation Oncology|April 29, 2024
Measurement and Incorporation of Laryngeal Motion Using cine-MRI on an MR-Linear Accelerator to Generate Radiation Therapy Plans for Early-stage Squamous Cell Cancers of the GlottisAmit Gupta, Dualta McQuaid, Alex Dunlop, et al.British Journal of Cancer|November 25, 2016
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neckLiam Welsh, Rafal Panek, Angela Riddell, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid CancerJan Taprogge, Carla Abreu, Siraj Yusuf, et al.JMIR Public Health and Surveillance|April 10, 2025
Assessing the Dissemination of Federal Risk Communication by News Media Outlets During Enteric Illness Outbreaks: Canadian Content AnalysisHisba Shereefdeen, Lauren Elizabeth Grant, Vayshali Patel, et al.Health Communication|August 22, 2024
Evaluating Multi-Jurisdictional Enteric Illness Outbreak Messaging in Canada: A Content Analysis of Public Health NoticesVayshali Patel, Lauren E Grant, Hisba Shereefdeen, et al.European Thyroid Journal|June 20, 2025
Molecular predictive biomarker testing in advanced thyroid cancer - a European consensusAleš Ryška, Jaume Capdevila, Matthias S Dettmer, et al.International Journal of Radiation Oncology, Biology, Physics|February 6, 2022
Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective StudyCarlos E Cardenas, Sanne E Blinde, Abdallah S R Mohamed, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.Journal for Immunotherapy of Cancer|August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancerEva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.European Thyroid Journal|October 13, 2022
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinomaChantal A Lebbink, Thera P Links, Agnieszka Czarniecka, et al.Pageof 9